ArticleOncotarget2014

The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism.

Anja Pickhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.